Published by Josh White on 20th February 2019
(Sharecast News) - Generic drugs manufacturer Beximco Pharmaceuticals announced the signing of a definitive agreement with Sandoz - a division of Novartis - to acquire a portfolio of eight 'Abbreviated New Drug Applications' (ANDAs) in the US on Wednesday, for an undisclosed amount in cash.
URL: http://www.digitallook.com/dl/news/story/28659484/...